{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:43:51Z","timestamp":1779353031740,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shandong Provincial Health Department, China","award":["No.2016WS0318"],"award-info":[{"award-number":["No.2016WS0318"]}]},{"name":"Shandong Provincial Natural Science Foundation, China","award":["No.ZR2016HM39"],"award-info":[{"award-number":["No.ZR2016HM39"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81702677"],"award-info":[{"award-number":["No. 81702677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1465-8","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T13:51:45Z","timestamp":1534254705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Zhiqiang","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinkun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shupei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"1465_CR1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3892\/ijo.2013.1829","volume":"42","author":"H Shiraha","year":"2013","unstructured":"Shiraha H, Yamamoto K, Namba M. Human hepatocyte carcinogenesis. Int J Oncol. 2013;42:1133\u20138.","journal-title":"Int J Oncol"},{"key":"1465_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1072-7515(00)00700-6","volume":"191","author":"K Hanazaki","year":"2000","unstructured":"Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381\u20138.","journal-title":"J Am Coll Surg"},{"key":"1465_CR3","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.3748\/wjg.v21.i28.8478","volume":"21","author":"A Schlachterman","year":"2015","unstructured":"Schlachterman A, Craft WW Jr, Hilgenfeldt E, Mitra A, Cabrera R. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol. 2015;21:8478\u201391.","journal-title":"World J Gastroenterol"},{"key":"1465_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2014.09.002","volume":"19","author":"LM Kulik","year":"2015","unstructured":"Kulik LM, Chokechanachaisakul A. Evaluation and management of hepatocellular carcinoma. Clin Liver Dis. 2015;19:23\u201343.","journal-title":"Clin Liver Dis"},{"key":"1465_CR5","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717\u201321.","journal-title":"Science"},{"key":"1465_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4161\/auto.26927","volume":"10","author":"P Chen","year":"2014","unstructured":"Chen P, Cescon M, Bonaldo P. Autophagy-mediated regulation of macrophages and its applications for cancer. Autophagy. 2014;10:192\u2013200.","journal-title":"Autophagy"},{"key":"1465_CR7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1101\/gad.1565707","volume":"21","author":"V Karantza-Wadsworth","year":"2007","unstructured":"Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 2007;21:1621\u201335.","journal-title":"Genes Dev"},{"key":"1465_CR8","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.bbamcr.2017.05.008","volume":"1864","author":"B Ma","year":"2017","unstructured":"Ma B, Yuan Z, Zhang L, Lv P, Yang T, Gao J, et al. Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy. Biochim Biophys Acta. 2017;1864:1393\u2013404.","journal-title":"Biochim Biophys Acta"},{"key":"1465_CR9","doi-asserted-by":"publisher","first-page":"26629","DOI":"10.3390\/ijms161125984","volume":"16","author":"YJ Lee","year":"2015","unstructured":"Lee YJ, Jang BK. The role of autophagy in hepatocellular carcinoma. Int J Mol Sci. 2015;16:26629\u201343.","journal-title":"Int J Mol Sci"},{"key":"1465_CR10","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1128\/JVI.72.11.8586-8596.1998","volume":"72","author":"XH Liang","year":"1998","unstructured":"Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol. 1998;72:8586\u201396.","journal-title":"J Virol"},{"key":"1465_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cdd.2010.191","volume":"18","author":"R Kang","year":"2011","unstructured":"Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571\u201380.","journal-title":"Cell Death Differ"},{"key":"1465_CR12","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1007\/s13277-014-2060-4","volume":"35","author":"Y He","year":"2014","unstructured":"He Y, Zhao X, Subahan NR, Fan L, Gao J, Chen H. The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis. Tumour Biol. 2014;35:7317\u201326.","journal-title":"Tumour Biol"},{"key":"1465_CR13","doi-asserted-by":"publisher","first-page":"15077","DOI":"10.1073\/pnas.2436255100","volume":"100","author":"Z Yue","year":"2003","unstructured":"Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1465_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/1471-2407-14-327","volume":"14","author":"DM Qiu","year":"2014","unstructured":"Qiu DM, Wang GL, Chen L, Xu YY, He S, Cao XL, et al. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance. BMC Cancer. 2014;14:327.","journal-title":"BMC Cancer"},{"key":"1465_CR15","doi-asserted-by":"publisher","first-page":"9167","DOI":"10.1158\/0008-5472.CAN-08-1573","volume":"68","author":"ZB Ding","year":"2008","unstructured":"Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, et al. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res. 2008;68:9167\u201375.","journal-title":"Cancer Res"},{"key":"1465_CR16","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.1007\/s13277-014-2531-7","volume":"35","author":"DH Wu","year":"2014","unstructured":"Wu DH, Jia CC, Chen J, Lin ZX, Ruan DY, Li X, et al. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumour Biol. 2014;35:12225\u201333.","journal-title":"Tumour Biol"},{"key":"1465_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"X Zeng","year":"2015","unstructured":"Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8:2\u201310.","journal-title":"J Evid Based Med"},{"key":"1465_CR18","doi-asserted-by":"crossref","first-page":"69087","DOI":"10.18632\/oncotarget.12011","volume":"7","author":"L Lu","year":"2016","unstructured":"Lu L, Wu M, Zhao F, Fu W, Li W, Li X, et al. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: a meta-analysis. Oncotarget. 2016;7:69087\u201396.","journal-title":"Oncotarget"},{"key":"1465_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.","journal-title":"Trials"},{"key":"1465_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264\u20139. w64","journal-title":"Ann Intern Med"},{"key":"1465_CR21","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3892\/ol.2013.1307","volume":"5","author":"KF Kang","year":"2013","unstructured":"Kang KF, Wang XW, Chen XW, Kang ZJ, Zhang X, Wilbur RR, et al. Beclin 1 and nuclear factor-kappaBp65 are upregulated in hepatocellular carcinoma. Oncol Lett. 2013;5:1813\u20138.","journal-title":"Oncol Lett"},{"key":"1465_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081540","volume":"8","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Hah YJ, Kang YN, Kang KJ, Hwang JS, Chung WJ, et al. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma. PLoS One. 2013;8:e81540.","journal-title":"PLoS One"},{"key":"1465_CR23","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1007\/s13277-015-3068-0","volume":"36","author":"NA Osman","year":"2015","unstructured":"Osman NA, Abd El-Rehim DM, Kamal IM. Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1alpha expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma. Tumour Biol. 2015;36:4293\u20139.","journal-title":"Tumour Biol"},{"key":"1465_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/apm.12498","volume":"124","author":"HA Al-Shenawy","year":"2016","unstructured":"Al-Shenawy HA. Expression of Beclin-1, an autophagy-related marker, in chronic hepatitis and hepatocellular carcinoma and its relation with apoptotic markers. APMIS. 2016;124:229\u201337.","journal-title":"APMIS"},{"key":"1465_CR25","first-page":"250","volume":"20","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Wu PW, Yuan XW, Li J, Shi XL. Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2\/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2016;20:250\u201363.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1465_CR26","first-page":"85","volume":"13","author":"XD Guo","year":"2013","unstructured":"Guo XD, Gao YJ, Wan W, Li RS, Zhou YX, Zhao JM, et al. Expression and clinical significance of Beclin 1 in patients with hepatocellular carcinoma. Progress in Modern Biomedicine. 2013;13:85\u20137.","journal-title":"Progress in Modern Biomedicine"},{"key":"1465_CR27","first-page":"108","volume":"36","author":"W Yang","year":"2015","unstructured":"Yang W, Yang HJ, Mo RX, Li XR, Liao WS, Zhang HM, et al. Expression of Beclin1 in human hepatocellular carcinoma and effects of TGF-\u03b2 on proliferation of hepatocellular carcinoma cells. Int J Lab Med. 2015;36:108\u20139.","journal-title":"Int J Lab Med"},{"key":"1465_CR28","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1007\/s13277-013-1049-8","volume":"34","author":"P Xia","year":"2013","unstructured":"Xia P, Wang JJ, Zhao BB, Song CL. The role of beclin-1 expression in patients with gastric cancer: a meta-analysis. Tumour Biol. 2013;34:3303\u20137.","journal-title":"Tumour Biol"},{"key":"1465_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080317","volume":"8","author":"TT Wang","year":"2013","unstructured":"Wang TT, Cao QH, Chen MY, Xia Q, Fan XJ, Ma XK, et al. Beclin 1 deficiency correlated with lymph node metastasis, predicts a distinct outcome in intrahepatic and extrahepatic cholangiocarcinoma. PLoS One. 2013;8:e80317.","journal-title":"PLoS One"},{"key":"1465_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5301\/JBM.2012.9769","volume":"28","author":"GH Liu","year":"2013","unstructured":"Liu GH, Zhong Q, Ye YL, Wang HB, Hu LJ, Qin ZK, et al. Expression of beclin 1 in bladder cancer and its clinical significance. Int J Biol Markers. 2013;28:56\u201362.","journal-title":"Int J Biol Markers"},{"key":"1465_CR31","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.3390\/ijms15045292","volume":"15","author":"M Cai","year":"2014","unstructured":"Cai M, Hu Z, Liu J, Gao J, Liu C, Liu D, et al. Beclin 1 expression in ovarian tissues and its effects on ovarian cancer prognosis. Int J Mol Sci. 2014;15:5292\u2013303.","journal-title":"Int J Mol Sci"},{"key":"1465_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.4161\/auto.7.8.15598","volume":"7","author":"S Lee","year":"2011","unstructured":"Lee S, Kim H, Jin Y, Choi A, Ryter S. Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis. Autophagy. 2011;7:829\u201339.","journal-title":"Autophagy"},{"key":"1465_CR33","first-page":"1453","volume":"27","author":"K Koneri","year":"2007","unstructured":"Koneri K, Goi T, Hirono Y, Katayama K, Yamaguchi A. Beclin 1 gene inhibits tumor growth in colon cancer cell lines. Anticancer Res. 2007;27:1453\u20137.","journal-title":"Anticancer Res"},{"key":"1465_CR34","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1101\/gad.1545107","volume":"21","author":"R Mathew","year":"2007","unstructured":"Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 2007;21:1367\u201381.","journal-title":"Genes Dev"},{"key":"1465_CR35","first-page":"5611","volume":"33","author":"J Tang","year":"2013","unstructured":"Tang J, Fang Y, Hsi E, Huang Y, Hsu N, Yang W, et al. Immunopositivity of Beclin-1 and ATG5 as indicators of survival and disease recurrence in oral squamous cell carcinoma. Anticancer Res. 2013;33:5611\u20136.","journal-title":"Anticancer Res"},{"key":"1465_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4161\/auto.6.3.11303","volume":"6","author":"X Wan","year":"2010","unstructured":"Wan X, Fan X, Chen M, Xiang J, Huang P, Guo L, et al. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy. 2010;6:395\u2013404.","journal-title":"Autophagy"},{"key":"1465_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/MPA.0b013e318279d0dc","volume":"42","author":"Y Ko","year":"2013","unstructured":"Ko Y, Cho Y, Won H, Jeon E, An H, Hong S, et al. Prognostic significance of autophagy-related protein expression in resected pancreatic ductal adenocarcinoma. Pancreas. 2013;42:829\u201335.","journal-title":"Pancreas"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-018-1465-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1465-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T19:33:08Z","timestamp":1604777588000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1465-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1465"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1465-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"20 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"170"}}